| Phase 2a randomized, placebo-controlled study of anti–IL-33 in peanut allergy S Chinthrajah, S Cao, C Liu, SC Lyu, SB Sindher, A Long, V Sampath, ... JCI insight 4 (22), 2019 | 149 | 2019 |
| Asthma phenotypes, associated comorbidities, and long‐term symptoms in COVID‐19 LE Eggert, Z He, W Collins, AS Lee, G Dhondalay, SY Jiang, J Fitzpatrick, ... Allergy 77 (1), 173-185, 2022 | 63 | 2022 |
| Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results … Y Sunakawa, S Stintzing, S Cao, V Heinemann, C Cremolini, A Falcone, ... Annals of Oncology 26 (12), 2450-2456, 2015 | 44 | 2015 |
| Biliary-enteric drainage vs primary liver transplant as initial treatment for children with biliary atresia E LeeVan, L Matsuoka, S Cao, S Groshen, S Alexopoulos JAMA surgery 154 (1), 26-32, 2019 | 43 | 2019 |
| Gastrointestinal eosinophil responses in a longitudinal, randomized trial of peanut oral immunotherapy BL Wright, NQ Fernandez-Becker, N Kambham, N Purington, S Cao, ... Clinical Gastroenterology and Hepatology 19 (6), 1151-1159. e14, 2021 | 42 | 2021 |
| Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia SP Alexopoulos, V Nekrasov, S Cao, S Groshen, N Kaur, YS Genyk, ... Liver Transplantation 23 (2), 221-233, 2017 | 36 | 2017 |
| Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer M Suenaga, M Schirripa, S Cao, W Zhang, D Yang, S Murgioni, D Rossini, ... Annals of Oncology 28 (5), 1015-1022, 2017 | 31 | 2017 |
| Improvement in health-related quality of life in food-allergic patients: a meta-analysis S Cao, M Borro, S Alonzi, S Sindher, K Nadeau, RS Chinthrajah The Journal of Allergy and Clinical Immunology: In Practice 9 (10), 3705-3714, 2021 | 29 | 2021 |
| Targeted DNA methylation profiling reveals epigenetic signatures in peanut allergy X Zhou, X Han, SC Lyu, B Bunning, L Kost, I Chang, S Cao, V Sampath, ... JCi insight 6 (6), 2021 | 29 | 2021 |
| A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab or FOLFIRI/cetuximab MD Berger, S Stintzing, V Heinemann, S Cao, D Yang, Y Sunakawa, ... Clinical Cancer Research 24 (4), 784-793, 2018 | 29 | 2018 |
| National outcomes of liver transplantation for model for end‐stage liver disease score≥ 40: the impact of Share 35 V Nekrasov, L Matsuoka, M Rauf, N Kaur, S Cao, S Groshen, ... American Journal of Transplantation 16 (10), 2912-2924, 2016 | 28 | 2016 |
| Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer Y Sunakawa, S Stremitzer, S Cao, W Zhang, D Yang, T Wakatsuki, Y Ning, ... Annals of Oncology 26 (2), 332-339, 2015 | 28 | 2015 |
| Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome X Jia, S Cao, AS Lee, M Manohar, SB Sindher, N Ahuja, M Artandi, ... JCI insight 7 (13), 2022 | 27 | 2022 |
| Oral immunotherapy for peanut allergy: the pro argument RS Chinthrajah, S Cao, T Dunham, V Sampath, S Chandra, M Chen, ... World Allergy Organization Journal 13 (8), 100455, 2020 | 27 | 2020 |
| Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand–Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib M Suenaga, M Schirripa, S Cao, W Zhang, D Yang, Y Ning, C Cremolini, ... Clinical colorectal cancer 17 (2), e395-e414, 2018 | 27 | 2018 |
| Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy S Matsusaka, DL Hanna, S Cao, W Zhang, D Yang, Y Ning, Y Sunakawa, ... Clinical Cancer Research 22 (13), 3218-3226, 2016 | 26 | 2016 |
| Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials MD Berger, S Yamauchi, S Cao, DL Hanna, Y Sunakawa, M Schirripa, ... European Journal of Cancer 77, 13-20, 2017 | 25 | 2017 |
| Patient-reported outcomes of the relative severity of side effects from cancer radiotherapy PA Williams, S Cao, D Yang, RL Jennelle Supportive Care in Cancer 28, 309-316, 2020 | 23 | 2020 |
| Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer M Suenaga, M Schirripa, S Cao, W Zhang, D Yang, V Dadduzio, ... European Journal of Cancer 86, 197-206, 2017 | 23 | 2017 |
| Predictive value of TLR7 polymorphism for cetuximab‐based chemotherapy in patients with metastatic colorectal cancer S Okazaki, S Stintzing, Y Sunakawa, S Cao, W Zhang, D Yang, Y Ning, ... International journal of cancer 141 (6), 1222-1230, 2017 | 22 | 2017 |
